Pediatric Interventional Cardiology Market Report 2026

Pediatric Interventional Cardiology Market Overview

• Pediatric Interventional Cardiology market size has reached to $2.6 billion in 2025 • Expected to grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Pediatric Population Surge Drives Growth In Pediatric Interventional Cardiology Market • Market Trend: Philips Unveils X11-4T Mini 3D TEE Transducer, Advancing Pediatric Interventional Cardiology With Enhanced Imaging For Congenital Heart Defects • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pediatric Interventional Cardiology Market?

Pediatric interventional cardiology refers to procedures that use cardiac catheterization in children to diagnose and treat congenital heart defects. Pediatric interventional cardiology is used for treating heart conditions with minimally invasive surgical procedures. The main pediatric interventional cardiology devices are closure devices, trans catheter heart valves, atherectomy devices, catheters, balloons, stents, and others. Closure devices refer to any cover, cap, hatch, lid, plug, seal, valve, or other type of fitting that, when fastened in the closed position, prevents or minimizes air emissions to the environment by sealing an opening in a container or its exterior. The main pediatric interventional cardiology procedures include catheter-based valve implantation, congenital heart defect correction, angioplasty, coronary thrombectomy, and others used in clinical testing laboratories, hospitals, cardiac centers, pediatric clinics, and research institutions.

What Is The Pediatric Interventional Cardiology Market Growth Forecast?

The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to expansion of next-generation pediatric cardiac devices, rising demand for less invasive treatment options, growing investments in pediatric cardiac infrastructure, integration of advanced imaging and navigation systems, increasing procedural success rates. Major trends in the forecast period include increasing adoption of minimally invasive cardiac procedures, rising use of transcatheter heart valves, growing demand for pediatric-specific cardiac devices, expansion of image-guided catheterization techniques, enhanced focus on early congenital defect intervention.

Global Pediatric Interventional Cardiology Market Segmentation

1) By Device Type: Closure Devices, Catheters 2) By Procedure: Congenital Heart Defect Closure Procedures, Balloon-Based Interventions, Transcatheter Pulmonary Valve Procedures, Ductal And Vascular Interventions, Hybrid And Other Pediatric Interventional Procedures 3) By End-Use: Hospitals, Cardiac Centers Subsegments: 1) By Closure Devices: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices 2) By Catheters: Diagnostic Catheters, Therapeutic Catheters, Guiding Catheters

What Are The Drivers Of The Pediatric Interventional Cardiology Market?

Pediatric population growth is expected to propel the growth of the pediatric interventional cardiology market. The pediatric population refers to the group of individuals within a specified age range that is typically associated with childhood and adolescence. Pediatric interventional cardiology involves the use of minimally invasive procedures to diagnose and treat various heart conditions in children. For instance, in September 2023, according to the Federal Interagency Forum on Child and Family Statistics (Forum), a US-based federal government agency, in 2022, the United States had about 72.5 million children, including 22.4 million aged 0–5, 24.2 million aged 6–11, and 25.8 million aged 12–17, with the total child population projected to increase to 78.2 million by 2050. Therefore, the pediatric population growth will drive the pediatric interventional cardiology industry. The increasing prevalence of congenital heart disease is expected to propel the growth of the pediatric interventional cardiology market. Congenital heart disease is any problem that has affected the heart and its structure since birth. Pediatric interventional cardiology procedures are used to treat congenital heart disease that advantages over traditional open-heart surgery, including shorter recovery times, reduced risk of infection, and less scarring. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based national public health agency, heart defects are the most common birth defects, impacting approximately 1% of births in the United States, which amounts to around 40,000 infants each year. Therefore, the increasing prevalence of congenital heart disease will drive the growth of the pediatric interventional cardiology industry.

Key Players In The Global Pediatric Interventional Cardiology Market

Major companies operating in the pediatric interventional cardiology market are Medtronic plc, Abbott Laboratories, Terumo Corporation, W. L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Biosensors International Group Ltd., Asahi Intecc Co Ltd, Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH

Global Pediatric Interventional Cardiology Market Trends and Insights

Major companies operating in the pediatric interventional cardiology market are focused on developing technological innovations, such as three-dimensional transesophageal echocardiography (3D TEE), to gain a competitive edge. In pediatric interventional cardiology, real-time 3D TEE provides detailed images of congenital heart defects, such as atrial or ventricular septal defects, which is essential for planning and guiding minimally invasive interventions. For instance, in January 2024, Philips, a Netherlands-based healthcare technology company, launched the smaller X11-4T Mini 3D TEE transducer. This advanced transducer enhances three-dimensional transesophageal echocardiography (TEE), providing detailed imaging crucial for diagnosing congenital heart defects in children. Unique features include its compact design that improves maneuverability in pediatric patients, high-resolution imaging capabilities that enhance diagnostic accuracy, and integration with existing echocardiography systems for seamless workflow. These advancements significantly improve procedural outcomes and patient care in pediatric cardiology.

Regional Outlook

North America was the largest region in the pediatric interventional cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pediatric Interventional Cardiology Market?

The pediatric interventional cardiology market includes revenues earned by entities by percutaneous coronary intervention services, atrial septal defect services, cardiac catheterization services, and trans-catheter aortic valve replacement services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pediatric interventional cardiology market also consists of sales of plaque modification devices, guide wires, vascular closure devices, and atherectomy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.